Shares of Genworth Financial, Inc. (NYSE:GNW) opened at $4.55, and ended 4.21% higher at $4.7. Nearly 6.58 million shares were traded by the close, higher than its average daily volume of 4.27 million shares.Genworth Financial, Inc. (GNW) Analyst Opinion
Genworth Financial, Inc. is currently rated as hold by 4 stock analysts, with the company still having around 2.35% shares outstanding that can be sold short legally. The value of their shares went up by 3.98% last month. Over the course of a year, the stock has grown by 51.13%. Financial analysts are becoming neutral than ever, with the 0 analysts who cover the activities of GNW advising investors to buy. Experts on Wall Street have set a price target of $4.5 for the stock. The decision was arrived after looking at their -4.26% decline from current levels. At the moment, Genworth Financial, Inc. (GNW) trading price is around -4.67% below its 52-week high.
Genworth Financial, Inc. (GNW) was successful in overcoming the expected $0.26 as the stock recorded an earnings of $0.29 a piece during their last financial report presentation. Revenue, meanwhile, had a distance of 0.19% from the previous quarter, with the company recording $2.16 billion in revenue.Genworth Financial, Inc. (NYSE:GNW) Intraday View
The shares of Genworth Financial, Inc. (NYSE:GNW) have struggled and recovered 76.69% ever since it recorded its 52 week low. During the course of 5 days, the stock price volatility has remained at 5.58%, increasing the time frame to a month, the volatility recorded was 4.3%. The price of their shares has been successful in staying above its 20 days moving average, staying at a distance of 5.56% and while its 50 moving average is around 8.7%. A look at previous five trading sessionGNW stock had returned 10.07% and has spiked 17.58% when compared to its 200-day moving average that is $4.43. Genworth Financial, Inc. (GNW) will look to keep its 46.87% increase that it witnessed in the past one year.
As the normal trading session ended, the stock of Boston Scientific Corporation (NYSE:BSX), fetched in a $1.95 spike to $33.68. The session began with the stock price at $32.6, hitting a high of $32.78 before down again. For the week, analysts seem to be okay with their bullish with the consensus call staying at 1.4. Boston Scientific Corporation gets 16 buy analyst recommendations while 2 recommend a hold and 0 rated it as a sell. The shares of the company tumbled -14.6% from its high $39.44, with their overall market value now roughly $48.14 billion.
The mean recommendation of BSX on Reuter’s scale upped from 1.41 to 1.42 within 30 days. This figure implies that the majority of analysts rate it as a buy. The price target for Boston Scientific Corporation (NYSE:BSX) is now around $42.41 a share, implying the stock has what it takes to grow by 25.92%. The recent trading session also indicated the stock needs to add 42.52% more meet analysts’ high consensus price target.
The current trading volume of the company was 6.56 million shares during the last session. That compares with the recent average volume of 7.9 million shares. By the end of the regular trading session, the price volatility over a 1-week span was 4.32 while month stood 3.47%. The stock price of BSX dropped to $31.56 during the day and at a certain time in 12 months it traded as low as $24.79. It has made a 35.86% recovery since its 52-week low point and has returned 35.86% year-to-date.